Find therapies in clinical trials near you – page 95

Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

Study on Ravulizumab for Children Aged 6 to 17 with Generalized Myasthenia Gravis

Study on the Effectiveness and Safety of Cisplatin and Paclitaxel in Advanced Ovarian Cancer Patients After Surgery

Study on the Effectiveness and Safety of Cisplatin and Paclitaxel in Advanced Ovarian Cancer Patients After Surgery

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Study on the Required Dose of Cholecalciferol for Managing Vitamin D Deficiency in Postmenopausal Women

Study on the Required Dose of Cholecalciferol for Managing Vitamin D Deficiency in Postmenopausal Women

Study on the Safety and Effectiveness of REGN5668 with Cemiplimab or Ubamatamab for Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Study on the Safety and Effectiveness of REGN5668 with Cemiplimab or Ubamatamab for Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Finding the Right Dose of Dobutamine for Very Preterm Infants with Heart and Blood Flow Issues

Finding the Right Dose of Dobutamine for Very Preterm Infants with Heart and Blood Flow Issues

Study on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis

Study on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis

Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

Study of Tebentafusp and Pembrolizumab for Patients with Previously Treated Advanced Melanoma

Study of Tebentafusp and Pembrolizumab for Patients with Previously Treated Advanced Melanoma